Physician profile
John K Burkus
NPI 1083656839
$599,409.83
in general payments reported to CMS, 2019-2025
11 companies · $58K in 2025
The $58K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118K · 2020: $79K · 2021: $35.96 · 2022: $112K · 2023: $110K · 2024: $123K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $289K · Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $289,196.32 |
| Food and Beverage | $1,192.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $575,397.08 | 2019-2025 | Sternalock 360 System |
| Nuvasive, INC. | $22,591.20 | 2019 | |
| Curiteva, INC. | $1,133.73 | 2023 | |
| Globus Medical, INC. | $66.70 | 2022-2023 | Sable |
| Pacira Therapeutics, INC. | $45.57 | 2020 | |
| Next Science LLC | $39.61 | 2020-2022 | |
| Vericel Corporation | $39.33 | 2022 | |
| Stryker Corporation | $35.96 | 2021 | |
| Orthofix Medical, INC. | $35.33 | 2024 | Osteostrand Plus |
| Avanos Medical | $25.32 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burkus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.